- Research works
- 96 ▲ 447% vs 2013–17
- Citations
- 1.3k 13.8 per fractional work
- Top-10% rate
- 19.0% record average 16.5%
- Open access
- 64% world 28%
Not ranked overall: Medical Governance Research Institute is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 23.3×. Every wedge is a field page.
- Pharmacology, Toxicology and Pharmaceutics 23.3×
- Economics, Econometrics and Finance 7.2×
- Health Professions 4.5×
- Psychology 2.2×
- Medicine 1.8×
- Veterinary 1.7×
- Mathematics 1.4×
- Immunology and Microbiology 1.2×
- Environmental Science 0.8×
- Social Sciences 0.8×
- Neuroscience 0.5×
- Business, Management and Accounting 0.5×
- Biochemistry, Genetics and Molecular Biology 0.5×
- Decision Sciences 0.4×
- Dentistry 0.3×
- Materials Science 0.1×
- Agricultural and Biological Sciences 0.1×
- Chemistry 0.1×
Who are the top researchers at Medical Governance Research Institute?
Ranked on the composite score, Tetsuya Tanimoto lead among researchers whose main affiliation is Medical Governance Research Institute.
- 1 Tetsuya Tanimoto Japan · #1,009,615 worldwide 29 citations · 33 works
Which keywords describe research at Medical Governance Research Institute?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Pharmaceutical Industry, Clinical Trials, Pandemic, Medical Ethics, Conflict of Interest, Research Outcome, Quality of Life and Public Health.
- Triage
- Disaster Response
- COVID-19 Vaccine
- Social Media
- Health Care Costs
- Risk Perception
- ACE2 Receptor
- Health Utility Measures
- Healthcare Workers
- COVID-19
- Ethical Considerations
- Drug Development Costs
- Medical Ethics
- Public Health
- Pandemic
- Clinical Trials
- Pharmaceutical Industry
- Epidemiology
- Quality of Life
- Conflict of Interest
- Research Outcome
- Generic Drugs
- Infectious Diseases
- Mental Health
- Cost-effectiveness Analysis
- SARS-CoV-2
- Global Access
- Health Behavior
- Resource Allocation
- Vaccine
- Depression
- Primary Care
- Vaccine Hesitancy
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 33 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 33 words, with their numbers
- Pharmaceutical Industry5▲ 349×2 topics
- Clinical Trials4▲ 15×8 topics
- Epidemiology3▲ 2.3×22 topics
- Pandemic3▲ 7.8×8 topics
- Quality of Life3▲ 5.5×15 topics
- Public Health3▲ 5.2×16 topics
- Conflict of Interest3▲ 797×1 topic
- Medical Ethics3▲ 55×2 topics
- Research Outcome3▲ 797×1 topic
- Drug Development Costs2▲ 225×1 topic
- Generic Drugs2▲ 225×1 topic
- Ethical Considerations2▲ 17×7 topics
- Infectious Diseases2▲ 17×6 topics
- COVID-192▲ 4.1×13 topics
- Mental Health2▲ 3.2×12 topics
- Healthcare Workers2▲ 18×2 topics
- Cost-effectiveness Analysis2▲ 48×1 topic
- Health Utility Measures2▲ 48×1 topic
- SARS-CoV-21▲ 12×4 topics
- ACE2 Receptor1▲ 15×3 topics
- Global Access1▲ 42×2 topics
- Risk Perception1▲ 13×2 topics
- Health Behavior1▲ 32×2 topics
- Health Care Costs1▲ 42×2 topics
- Resource Allocation1▲ 18×2 topics
- Social Media1▲ 2.3×4 topics
- Vaccine1▲ 8.0×5 topics
- COVID-19 Vaccine1▲ 40×1 topic
- Depression1▲ 3.4×6 topics
- Disaster Response1▲ 41×1 topic
- Primary Care1▲ 8.2×5 topics
- Triage1▲ 73×1 topic
- Vaccine Hesitancy1▲ 43×1 topic
Which research topics does Medical Governance Research Institute publish most on?
By volume in 2022–2025: Pharmaceutical industry and healthcare, Pharmaceutical Economics and Policy, Health Systems, Economic Evaluations, Quality of Life and Vaccine Coverage and Hesitancy.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Pharmaceutical industry and healthcare Pharmacology 3 works
- 2 Pharmaceutical Economics and Policy Economics and Econometrics 2 works
- 3 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 2 works
- 4 Vaccine Coverage and Hesitancy Health 1 works
- 5 Disaster Response and Management Emergency Medical Services 1 works
- 6 SARS-CoV-2 and COVID-19 Research Infectious Diseases 1 works
- 7 Radioactive contamination and transfer Global and Planetary Change 1 works
- 8 Healthcare cost, quality, practices General Health Professions 1 works
- 9 Palliative Care and End-of-Life Issues Public Health, Environmental and Occupational Health 1 works
- 10 Influenza Virus Research Studies Epidemiology 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Medical Governance Research Institute's research output changed?
Output in 2018–2022 was 447% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Tokyo
- The University of Tokyo
- Tokyo Institute of Technology
- Keio University
- Waseda University
- Tokyo University of Science
- Nihon University
- Hitachi (Japan)
- NTT (Japan)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.